Tmi Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Secunderabad, Telangana, India, established in 2014.
2014 Secunderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Tmi Pharmaceuticals Private Limited

Tmi Pharmaceuticals Private Limited, a struck off private limited company, was established on 01 July 2014 in Secunderabad, Telangana, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100TG2014PTC094681. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as Teva Med India Private Limited. Its leadership includes Sampath Chintala (Director), Saritha Chintala (Director). Past directors included Odelu Gunda, Krishna Vemula, Mahesh Kura. It is based at Flat No: 304, H. No: 6-1-132/77A Skandhagiri Asn Towers, Padmarao Nagar, Secunderabad, Telangana, 500061.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2014PTC094681

  • Registration Number

    094681

  • Incorporation Date

    01 July 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 8 Months
Company report

Tmi Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Tmi Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Tmi Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sampath Chintala Director 05 May 2017 Current
Saritha Chintala Director 05 May 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 13 May 2017 Past
Pramod Abcsdd Director 05 May 2017 Past
Pramod Abcsdd Director 04 Jan 2017 Past
Pramod Abcsdd Director 13 May 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tmi Pharmaceuticals.

Enhance accessibility to Tmi Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Tmi Pharmaceuticals revenue growth over time
Tmi Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tmi Pharmaceuticals?

Unlock access to Tmi Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Tmi Pharmaceuticals?

Unlock and access historical data on people associated with Tmi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tmi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tmi Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tmi Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Sampath Chintala was appointed as a Director was appointed as a Director on 05 May 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Saritha Chintala was appointed as a Director was appointed as a Director on 05 May 2017 & has been associated with this company since 8 years 9 months . was documented.

  • Company Incorporation

    Progress on Tmi Pharmaceuticals Private Limited was registered on 01 Jul 2014 with Roc Hyderabad & aged 11 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Tmi Pharmaceuticals Private Limited?

The CIN of Tmi Pharmaceuticals Private Limited is U24100TG2014PTC094681.

Where is Tmi Pharmaceuticals Private Limited headquartered?

Tmi Pharmaceuticals Private Limited is headquartered at Flat No: 304, H. No: 6-1-132/77A Skandhagiri Asn Towers, Padmarao Nagar, Secunderabad, Telangana, 500061.

When was Tmi Pharmaceuticals Private Limited incorporated?

Tmi Pharmaceuticals Private Limited was incorporated on 01 July 2014.

Who are the current directors of Tmi Pharmaceuticals Private Limited?

The current directors of Tmi Pharmaceuticals Private Limited are

What is the primary industry of Tmi Pharmaceuticals Private Limited?

The primary industry of Tmi Pharmaceuticals Private Limited is Chemicals.

Is Tmi Pharmaceuticals Private Limited a listed company?

Tmi Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Tmi Pharmaceuticals Private Limited?

The authorized capital of Tmi Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available